Slingshot members are tracking this event:

Celyad(CYAD) initiates Phase 1 SHRINK and LINK trials of CYAD-01 in colorectal cancer patients diagnosed with unresectable liver metastases

Do you think this event is important to the companies below? How will it affect their stock price?

Related Companies
High Medium Low
Impact on Stocks
CYAD Community voting in process
Slingshot Insights Explained
Catalyst Date
Occurred on:
May 03, 2018
Related Projects Image
  • Don’t see a project related to the catalyst you care about?

Related Keywords Shrink, Link, Cyad-01, Colorectal Cancer